IQVIA Holdings Inc. (IQV)
Health Care – SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Headquarters
- United States
- Employees
- 94,000
- Market Cap
- $40.7B
About IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
SentiSense also tracks daily options readings for IQVIA Holdings Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
IQVIA Holdings Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.